CLINICAL_TRIALS
research
· 2017-04-05
Clinical Trial Update: SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
Summary
The STAR Registry, a registry for systemic sclerosis (scleroderma) sponsored by NIAID, has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Scleroderma, Systemic, Sclerosis | Status: COMPLETED